Also found in: Dictionary, Encyclopedia.


something that enlarges or prolongs; called also expander.
artificial plasma extender (plasma volume extender) a substance that can be transfused to maintain fluid volume of the blood in event of great necessity, supplemental to the use of whole blood and plasma. Called also plasma volume expander.


A carbohydrate starch derivative used as a cryoprotective agent for erythrocytes; also used as an extender of blood plasma volume.


/het·a·starch/ (het´ah-stahrch) an esterified amylopectin-containing starch, used as a plasma volume expander, administered by infusion.


a plasma volume expander.
indications It is prescribed to treat hypovolemia in shock and is used in leukapheresis to help increase the yield of granulocytes.
contraindications Severe bleeding, severe heart or kidney dysfunction with oliguria or anuria, or known hypersensitivity to this drug prohibits its use.
adverse effects Among the more serious adverse reactions are influenza-like symptoms, muscle pain, edema, and anaphylaxis.


an artificial colloid produced by addition of hydroxyethyl ether groups into amylopectin; used as a plasma volume expander for treatment of shock.

Patient discussion about hetastarch

Q. i have a ex boyfriend who is 57 i think hes a alcoholic or something or bipolar.. his personality flip flops. well wondering what is causing this maybe midlife crisis .. i asked something is going on... he thinks he's fine.

A. he seems to have control issues. and just went to court on a domestic voilence charge he never hit me, but he been verbally abuse and emotionally, which i would not stand for.. he sweet one minute then two hours later. hes threatening..

More discussions about hetastarch
References in periodicals archive ?
Intravenous hetastarch was used in 5 patients and 4 of them showed excellent improvement and 1 had partial improvement.
Prevention of hypotension after spinal anesthesia for cesarean section:six percent hetastarch versus lactated ringer's solution, Anesth.
Birds were divided into 4 groups: untreated (control group) and treated with intravenous hetastarch (haes group), with a hemoglobin-based oxygen carrier (hemospan group), or by autotransfusion (blood group).
Ringer's lactate solution was given iv to replace intraoperative fluid maintenance requirements and 6% hetastarch (HES 130/0.
Hetastarch and Dextran 70 are selected in cases of hypoproteinemia.
Cryobanks previously employed a hetastarch method to process cord blood units.
After infusing 500 ml of ringer lactate, 500 ml of hetastarch was given to prevent fluid overload.
She was successfully resuscitated with 3 litres of lactated Ringer's solution, 500 ml of 6% hetastarch, 50 mg ephedrine, 600 [micro]g phenylephrine, 550 [micro]g adrenaline, 10 mg dexamethasone and 20 mg diphenhydramine.
Initial fluid support consisted of administration of 6% hetastarch (60 ml slow IV over 15 minutes) and 120 ml of 2.
Additionally, using PrepaCyte-CB to process cord blood returns more stem cells with hematopoietic reconstitution (blood-forming) potential versus hetastarch.
Prevention of hypotension during spinal anaesthesia: A comparison of intravascular administration of hetastarch versus lactated ringer's solution.
Not needing significant pH adjustment, the SID of their standard vehicles, usually saline, is likely to be zero; for example the 6% hetastarch preparation in Table 1.